Related Experiment Video
Updated: May 15, 2026
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Stem cell therapy for chronic heart failure: an updated appraisal
Simon Maltais1, Steven J Joggerst, Antonis Hatzopoulos
1Vanderbilt Heart, Cardiac Surgery, Nashville, USA simon.maltais@vanderbilt.edu
Expert Opinion on Biological Therapy
|January 8, 2013
Summary
Stem cell therapy shows promise for heart failure but faces challenges in clinical translation. Further research is needed to optimize timing, delivery, and survival factors for sustained patient benefits.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Cardiac cell-based therapies have advanced, with early trials showing promise for heart function restoration.
- Translational studies from animal models to human clinical trials have faced challenges in achieving sustained improvements.
Purpose of the Study:
- To provide an updated overview of stem cell populations for chronic heart failure.
- To critically review clinical trials in advanced heart failure patients.
- To present future directions in cardiac cell-based therapies.
Main Methods:
- Review of current literature on stem cell populations in heart failure.
- Critical analysis of completed and ongoing clinical trials.
- Identification of emerging research avenues and therapeutic strategies.
Main Results:
- Despite initial promise, stem cell efficacy in human trials for heart failure remains limited.
- Animal study successes have not consistently translated to sustained clinical benefits in humans.
- Unresolved issues regarding optimal therapeutic parameters persist.
Conclusions:
- Key questions regarding the mechanisms of stem cell therapeutics require further investigation.
- Human studies highlight critical unresolved issues in stem cell therapy for heart failure.
- Optimizing timing, delivery methods, and prosurvival factors is crucial for advancing the field and realizing the potential of cardiac cell-based therapies.
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...